Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-21-024888

EVP, General Counsel sold 50,455 shares at an average $82.46 ($4,160,559)

  • EVP, General Counsel acquired 97,001 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rivera Jose E · EVP, General Counsel

Table I: Non-derivative

25 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-01 Exercise or conversion : show line 1 in the form +33,000 $13.88 $458,040 148,842 D
2021-04-01 Sale : show line 2 in the form −2,010 $80.79 $162,388 146,832 D
2021-04-01 Sale : show line 3 in the form −8,266 $81.89 $676,903 138,566 D
2021-04-01 Sale : show line 4 in the form −3,233 $82.76 $267,563 135,333 D
2021-04-01 Sale : show line 5 in the form −3,234 $83.91 $271,365 132,099 D
2021-04-01 Sale : show line 6 in the form −1,067 $84.94 $90,631 131,032 D
2021-04-01 Exercise or conversion : show line 7 in the form +21,000 $18.30 $384,300 152,032 D
2021-04-01 Sale : show line 8 in the form −1,256 $80.82 $101,510 150,776 D
Open-market sales · 50,455 sh · avg $82.46 · $4,160,559

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-04-01 Exercise or conversion : show line 26 in the form Stock Option (right to buy) −33,000 39,000 D
2021-04-01 Exercise or conversion : show line 27 in the form Stock Option (right to buy) −21,000 29,090 D
2021-04-01 Exercise or conversion : show line 28 in the form Stock Option (right to buy) −10,000 51,000 D
2021-04-01 Exercise or conversion : show line 29 in the form Stock Option (right to buy) −33,001 6,116 D
Loading xslF345X03/doc4.xml…